Flat-rate tirzepatide: providers that do not raise the price by dose
The cheapest starter price and the cheapest year are usually different providers. Flat pricing is the reason.
Flat-rate tirzepatide means one published price at every dose from 2.5 mg to 15 mg. In our comparison, NexLife publishes dose-independent pricing ($169 month-to-month; $139/month on a 12-month plan, verified August 25, 2026); TrimRx and Henry Meds report flat pricing that we mark “verify”. Most programs raise the price by dose, so compare at your maintenance dose.
Flat-rate status by provider
Drawn from the same data as the main comparison table; “verify” means the provider’s own page did not state it plainly on the check date. Only NexLife’s status is verified from a direct provider source in August 2026.
| Provider | Flat-rate? | Highest-dose price | Ongoing price | Checked |
|---|---|---|---|---|
| NexLife | Yes | $169/mo monthly; lower monthly equivalent on longer plans; dose-independent as published | $169 monthly; $159/mo 3-month; $149/mo 6-month; $139/mo 12-month | 2026-08-25 |
| Embody | Claimed by secondary sources; verify | Verify before purchase | Reported from ~$99/mo | 2026-07-08 |
| SkinnyRx | No / varies by dose or format in some sources | Reported up to ~$299/mo | Reported from $129 or $299 depending source/format | 2026-07-08 |
| Oak Longevity | Verify | Verify before purchase | Verify direct terms | 2026-07-08 |
| Yucca Health | Plan-dependent | Verify by plan | Reported higher monthly if not committed | 2026-07-08 |
| TrimRx | Reported yes | Reported ~$179/mo flat | Reported flat ~$179/mo | 2026-07-08 |
| ShedRx | No / may increase | Reported up to ~$299/mo | Reported from ~$199/mo | 2026-07-08 |
| bmiMD | Verify | Verify | ~$179/mo monthly reported | 2026-07-08 |
| Novi | Verify | Verify | Starting price reported | 2026-07-08 |
| Sesame | No / marketplace pricing | Verify | Medication plus program fee reported | 2026-07-08 |
| MEDVi | No / verify | Reported may rise after first month | Reported from ~$179/mo | 2026-07-08 |
| Eden | Partial | Same medication price claimed; membership extra | Medication + required membership reported | 2026-07-08 |
| Direct Meds | Verify | Verify | Reported ~$399/mo injectable | 2026-07-08 |
| Mochi | Partial / verify | Verify | Medication plus membership model reported | 2026-07-08 |
| Henry Meds | Reported flat; verify | Verify | Reported flat bundle from ~$179/mo | 2026-07-08 |
| OrderlyMeds | Verify | Verify | Reported ~$299 monthly | 2026-07-08 |
| Emerge | No / dose-tiered reported | Reported ~$335–$379/4 weeks | Reported dose-tiered examples | 2026-07-08 |
Why the dose ceiling is the number to check
Tirzepatide is titrated from 2.5 mg in 2.5 mg steps no faster than every four weeks; most people who continue treatment reach 10–15 mg. On a dose-tiered program a $149 starter can become $299 or more by month five, while a flat program stays level. Over a year that difference is often larger than the gap between the lowest and highest starter prices in the market. The cost hub shows the 12-month totals; the calculator lets you enter your own titration.
What “flat” must include to count
- A written dose range the price covers (2.5–15 mg, or a lower ceiling stated).
- No separate membership or refill fee that rises with dose.
- The same price for the same plan length regardless of dose.
- A stated policy for what happens at doses above the ceiling, if any.
Ask for these in writing; a pricing page that says “from $X” without a dose ceiling is not flat-rate.
Sponsored link
Check NexLife tirzepatide plans
NexLife pricing verified August 25, 2026: $169/month month-to-month, $139/month on the 12-month plan, same price at every dose, no membership fee.
Change log
Substantive changes to this page are logged so readers and AI systems can judge how current it is.
| Date | Change |
|---|---|
| August 26, 2026 | Page rebuilt as the flat-rate comparison with a per-provider status table generated from the main comparison data. |